Bicalutamide

Bicalutamide is a non-steroidal androgen receptor antagonist used as part of combined androgen blockade in the treatment of prostate cancer. Simson Pharma's Bicalutamide reference standard and impurities support compendial testing for this widely used oncology agent.

Simson Pharma Global Ltd. (UK) and Simson Pharma Global LLC (USA) supply high-quality Bicalutamide Reference Standards, pharmacopoeial reference materials, and its related impurities to pharmaceutical manufacturers, CROs, analytical laboratories, universities, and regulatory organizations worldwide. To service the Europe and America market efficiently, Simson Pharma Limited has set up Simson Pharma Global Ltd. in United Kingdom and Simson Pharma Global LLC in USA respectively.

Pharmaceutical Reference Standards / Impurity Standards

Bicalutamide
Bicalutamide EP Impurity D
3-Fluorophenyl Bicalutamide
Bicalutamide EP Impurity J
Bicalutamide EP Impurity A
Bicalutamide EP Impurity B
Bicalutamide EP Impurity C
Bicalutamide Epoxide Impurity
4-Amino-3-(triflouromethyl) Benzonitrile   
Bicalutamide EP Impurity E (USP RC A)
Bicalutamide EP Impurity H
Bicalutamide Aminobenzonitrile
Bicalutamide Sulfoxide
(R,R)-Bicalutamide Sulfoxide
Bicalutamide Impurity 6
Bicalutamide EP Impurity K
Bicalutamide EP Impurity L
Bicalutamide EP Impurity M
Bicalutamide EP Impurity F
Bicadiol
(R)-Bicalutamide
(S)-Bicalutamide
Bicalutamide (form II)
Bicalutamide Impurity 9
4-Fluorophenyl methyl sulfone
Bicalutamide Impurity G
Bicalutamide Impurity I
Bicalutamide Impurity O
Bicalutamide Impurity P
Ethyl-4-fluorobenzenesulfonate
N-Nitroso Bicalutamide
Cyanophenolutamide
Bicalutamide Impurity 1

Isotope Labelled Compounds

Bicalutamide-D4
Bicalutamide D5